Febrile neutropenia (FN) is the most common haematological toxicity associated with cytotoxic chemotherapy. Individual studies are available, but national estimates on FN are required. To describe chemotherapy-induced neutropenia, its associated infection-causing organisms, and the antimicrobials prescribed, a prospective cum retrospective study was conducted for a period of 9 months, which included 50 paediatric cancer patients less than 18 years. Patients having an absolute neutrophil count (ANC) less than 1500/mm 3 , having body temperature of above 38.5°C, and receiving anti-infectives as prophylaxis were included. Patient demographic details, presenting complaints, absolute neutrophil count, and laboratory findings were noted in a patient proforma. Out of the overall 584 episodes of CIN, 188 episodes (32.2%) were of febrile neutropenia. Majority of patients were boys (70%), aged between 1 and 6 years (66%), and diagnosed with acute lymphoblastic leukemia (64%). The mean ANC was 765.6 ± 235.7 × 10 9
Introduction
Children present with different types of cancer when compared with adults, of which acute lymphoblastic leukemia (ALL) is the most common childhood cancer [1] . Febrile neutropenia is the most common haematological toxicity associated with cancer chemotherapy. Febrile neutropenia (FN) is defined as an absolute neutrophil count (ANC) of < 500 mm 3 or an ANC expected to decrease to < 500 mm 3 during the next 48 h with a body temperature of > 38.5°C [2, 3] . Patients with FN are at risk of infection from all types of microbes including gram-positive and gram-negative bacteria, fungi, and viruses. FN is a potentially life-threatening condition, and as the progression of infection in neutropenic patients can be rapid, such patients should receive empirical antibiotic therapy immediately after blood cultures are obtained and before any other diagnostic procedures are performed [4] . The causative microorganisms in blood culture were demonstrated in 70-80% of FN episodes [3] . However, majority of gram-negative microorganisms was responsible for causing 80% of infections in FN patients [5] . The choice of empirical therapy should be based on a variety of factors such as patient infection risk, known local epidemiology of infections, local antimicrobial sensitivity and resistance patterns, and available evidence from the literatures. The risk of infection depends on the severity of neutropenia [4] . Treatment of patients diagnosed with FN is an oncological emergency, and initiation of antimicrobials at the earliest is necessary. Species such as Escherichia coli, Klebsiella pneumonia, Enterococcus species, Non-candida albicans, and Erysipelothrix rhusiopathie were sensitive towards first-line agents such as piperacillin-tazobactam alone or in combination with Amikacin or Meropenem. Second-line agents such as imipenem, meropenem, or linezolid help significantly reduce This article is part of the Topical Collection on Medicine * Nissi Lisa Abraham nissiabraham61@gmail.com the episodes of FN [6] . Leukemias are the leading cause of FN at our hospital. Large-scale Indian studies are necessary to determine the appropriate preemptive therapy to decrease FN-related infections in paediatric cancer patients.
Materials and Methods
A prospective cum retrospective observational study was carried out among 50 paediatric cancer patients from Bharati Hospital, Pune. The study duration was from August 2017 to April 2018 for a period of 9 months. The study protocol was approved by the Institutional Research Committee of Bharati Hospital and Research Centre, Pune. Patient caretaker informed consent and informed patient assent form for children above 12 years were taken before initiating the study. All the patients were ensured confidentiality. Children and adolescents (less than 18 years) with paediatric cancer receiving chemotherapeutic agents and patients with neutropenia having an absolute neutrophils count of less than 1500/mm 3 , having body temperature of > 38.5°C, and receiving prophylactic treatment with anti-infective were included in this study. However, patients who underwent bone marrow or stem cell transplantation, having neutropenia other than chemotherapy, and those not willing to participate were excluded from the study. The patient details like demographics, presenting complaints, ANC during febrile neutropenia, drug therapy during FN, and laboratory findings such as complete blood count (CBC), culture sensitivity tests, and antimicrobial sensitivity tests were noted in patient profile form. Data analysis was done using mean and standard deviation.
Results
A total of 50 paediatric cancer patients presented with 584 episodes of CIN during the study period, out of which 188 episodes were of FN (32.19%) (Fig. 1) . The mean age of the study subjects was 5.94 ± 4.10 years (range, < 1 year-18 years). Highest reported incidence of FN was in boys (70%) between the age group of 1-6 years (66%) diagnosed with ALL (64%) ( Table 1) . The mean ANC during neutropenia was 765.6 ± 235.7 × 10 9 /l. From a total of 188 episodes of FN, in 179 episodes, patients had ANC < 500 mm 3 , whereas in 9 episodes, patients had ANC < 100 mm 3 . Predominant site of infection in patients with febrile neutropenic episodes was bloodstream (27%), followed by urine (6%) and stool (1%) (Figs. 2 and 3 ). Staphylococcus species (49%) was the most common isolate in blood culture, whereas in both urine and stool cultures, Escherichia coli (61.5%) were isolated. Piperacillin/vancomycin (56%) or amikacin (42%) prescribed in patients was found to be sensitive towards Klebsiella pneumonia (14.3%), Escherichia coli (14.3%), Staphylococcus aureus (20%), Erysipelothrix rhusiopathie (5.7%), Enterococcus (17.1%), and Pantoea species (20%). The most commonly used antifungal agent amphotericin B was sensitive towards non-Candida albicans species (8.6%), as shown in (Table 3 ). The first-line combination antimicrobial therapy prescribed majorly for patients was piperacillin/vancomycin (56%) and piperacillin/amikacin (42%). Second-line combinational drugs prescribed were meropenem with amikacin (6%) and meropenem with vancomycin (16%). Patients received empiric antibiotic therapy in 14 episodes and duo therapy with antibiotics in 46 episodes, from an overall of 90 episodes of drug therapy. Patients with positive fungal growth received amphotericin (18%) as therapy as shown in (Table 2) .
Discussion
FN is a common complication of the most prevalent childhood malignancy. In our study, ALL was mostly diagnosed among neutropenic cancer patients accounting for 64% cases. It was due to the involvement of bone marrow and the intensity of Fig. 1 Site of infection in patients with febrile neutropenic episodes chemotherapy regimen used to treat hematologic malignancy. Similar Indian study conducted by Biswal et al. also reported that ALL (59.8%) was frequently diagnosed in adult cancer patients with neutropenia [7] . In the present study, FN was observed slightly more common in boys (70%); the number of boys admitted to oncology department was high as compared to girls in general [8] . This finding was similar to a study conducted in Egypt where majority of patients were male (58%) [2] . Age also plays an important role in the occurrence of neutropenia and FN. In the current study, majority of the patients with FN were in the age group of 1 to 6 years (66%) when compared to those above 6 years. It is possible that there are differences in the primary cancer type, pharmacokinetics of chemotherapy received, and its tolerance among the two age groups [5] . A paediatric study conducted by Inaba et al. also reports the same [9] . The measure of the number of neutrophil count in blood is the absolute neutrophil count (ANC) [10] . The mean ANC in the present study was documented to be 765.6 ± 235.7 × 10 9 /l. The neutrophil cells required to fight bacteria are depleted during neutropenia. Thus, it increases the susceptibility to develop febrile neutropenia. Various other studies conducted by Timothy et al. in children and Krishnamani et al. in adults reported that in cancer patients, low ANC (< 500/mm 3 ) were harbingers for infections [11, 12] . Early and appropriate detection of infection in cancer patients is necessary to optimize patient outcomes. The predominant site of infection in the present study for febrile neutropenic patients was bloodstream accounting for 51 episodes (27%). Staphylococcus species (49%) was the most common isolate in blood culture, and patients with cancer are fitted with partially or totally implantable intravenous catheters more often than in the past, a fact that might explain the increasing number of gram-positive staphylococcal infections [13] . This was in good agreement with a study conducted in paediatric cancer patients in Pakistan by Bhatti et al. where bloodstream (40.6%) infections were the highest reported [14] . Similar adult studies conducted in Oman and India reported that the most common sites of infection in the neutropenic patients were bloodstream (88%) [4, 15] . However, in another study, it was reported that urinary tract infections were the most common occurrence in children [12] . Intensive chemotherapy with prolonged periods of febrile neutropenia contributes to development of infections in paediatric cancer patients. In most countries of the region, gram-negative bacteria are the prevailing etiological agent of infections in febrile neutropenic patients [16] . The widespread practice of immediate hospitalization and administration of iv broad-spectrum antibiotic therapy for all patients with febrile neutropenia has increased patients' risk of acquiring serious infections. In the current study, overall, 55 episodes (29.3%) of the microbiologically defined infections were bacterial and 9 episodes (4.8%) were fungal infections. Out of the overall bacterial species identified, gram-positive organisms in 32 episodes (17%) were mostly isolated as compared to gram-negative organisms in 23 episodes (12.2%). Different centres experience different patterns of principal causative pathogens. Over the last few decades, a shift has occurred from FN associated mainly with gram-negative bacteria to FN associated with gram-positive organisms. The possible reasons for this shift are better control Solid tumor cancer 6 1 2 Fig. 2 Organisms isolated in blood culture during febrile neutropenia episodes of gram-negative infections with newer ultra-broad spectrum antibiotics, fluoroquinolone prophylaxis, and increase use of long dwelling intravenous devices. An increase in antibioticresistant strains such as extended-spectrum b-lactamase (ESBL)-producing gram-negative bacteria, vancomycinresistant enterococci (VRE), and methicillin-resistant Staphylococcus aureus (MRSA) has been noted. Gramnegative bacteremia may be relatively more frequent in lowincome settings due to the absence of central venous lines [17, 18] . Similar suggestive results in studies conducted in paediatric neutropenic patients in Turkey by Celkan [19] and Sweden by Bjorkholm et al. [20] reported that gram-positive organisms were more pre-dominant by 60-69%. However, gram-negative bacteria pre-dominance was reported by Baskaran et al. (60.4%) in adults and Kanafani et al. (78.8%) in children of age in their studies [21, 22] . The importance of coverage for gram-negative pathogens in empirical therapy remains high, not only because of their virulence, but also because they still cause the majority of infections, if sites of infection other than blood are considered [13] . The choice of empiric therapy depends on the locally prevalent pathogens and their sensitivity patterns. This study identified that piperacillin/tazobactam was sensitive to grampositive Staphylococcus aureus, Streptococcus, Erysipelothrix rhusiopathie, and Enterococcus and gram-negative Klebsiella pneumonia and Escherichia coli. Similar findings were published in paediatric studies conducted in Turkey and the UK where gram-negative pathogens were sensitive to a combination of piperacillin/tazobactam with amikacin [23, 24] . Again, in this study, children receiving meropenem as monotherapy or in combination with amikacin/vancomycin were sensitive to gramnegative pathogens which includes Escherichia coli and Klebsiella pneumonia. This was similar to a finding reported in an Indian adult study conducted by Babu et al., where imipenem and meropenem demonstrated more than 70% efficacy toward the gram-negative isolates [25] . The most commonly used antifungal agent in the present study was amphotericin B, sensitive towards non-Candida albicans and Aspergillus species, which was similar among 6% adult patients in a study conducted in the USA [26] . In this study, amphotericin B was the prescribed anti-fungal agent, sensitive to non-Candida albicans and Aspergillus species [27] (Table 3) .
Antibiotics have significantly improved the outlook for cancer patients. In the present study, the first-line combination antimicrobial therapy prescribed majorly for patients was Inj. piperacillin with Inj. vancomycin (56%) and Inj. piperacillin with Inj. Fig. 3 Organisms isolated in urine culture during febrile neutropenia episodes Anti-fungal Amphotericin 9 18
Anti-viral Oseltamavir 32 48 [29] following monotherapy with cephalosporins or a carbapenem were considered as standard therapy [30] . Patients with positive fungal growth received Inj. amphotericin B (18%) as therapy which was similarly documented in an adult study in the USA (6%) [31] .
Conclusion
FN is the most common complication of childhood malignancies. The result of our study reported that nearly half of the study subjects undergoing intense chemotherapy had FN. It was majorly documented in patients diagnosed with haematological malignancies. Severe and prolonged neutropenia is life threatening. This leads to various bacterial and fungal infections in patients. Identification and evaluation of the microorganisms responsible for causing the infection and antimicrobial sensitivity reports are necessary. This could help in faster selection of appropriate antimicrobials necessary for treatment.
